NCT02644850

Brief Summary

To compare the calculated biventricular ejection fraction from cadmium-zinc-telluride (CZT) single photon emission computed tomography (SPECT) with planar equilibrium radionuclide angiography (ERNA), first-pass radionuclide ventriculography (FP-RNV) and echocardiogram.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 1, 2016

Status Verified

December 1, 2015

Enrollment Period

1.2 years

First QC Date

December 29, 2015

Last Update Submit

December 30, 2015

Conditions

Ventricular Dysfunction

Outcome Measures

Primary Outcomes (1)

  • Measure the biventricular ejection fraction

    Through study completion, an average of 3 years

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients underwent transthoracic echocardiogram and resting cardiac function within interval of 90 days of each other

You may qualify if:

  • Patients underwent transthoracic echocardiogram and resting cardiac function within interval of 90 days of each other

You may not qualify if:

  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital and National Taiwan University College of Medicine

Taipei, 100, Taiwan

RECRUITING

MeSH Terms

Conditions

Ventricular Dysfunction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Mei-Fang Cheng, M.D.

    National Taiwan University Hospital and National Taiwan University College of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mei-Fang Cheng, M.D.

CONTACT

886-2-23123456meifang@ntuh.gov.tw

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2015

First Posted

January 1, 2016

Study Start

October 1, 2015

Primary Completion

December 1, 2016

Study Completion

December 1, 2018

Last Updated

January 1, 2016

Record last verified: 2015-12

Data Sharing

IPD Sharing
Will not share

Locations

TW(1)